Skip to main content

K36 Therapeutics: Ph1 KTX-1001 Oral, FIC, MMSET Cat Inhib in Pts w/ RRMM

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

K36 Therapeutics

Start Date

April 11, 2023

End Date

March 31, 2028
 

Administered By

Duke Cancer Institute

Awarded By

K36 Therapeutics

Start Date

April 11, 2023

End Date

March 31, 2028